Ocrelizumab Treatment Modulates B-Cell Regulating Factors in Multiple Sclerosis.

Neurol Neuroimmunol Neuroinflamm · 2023 · PMC9880874 · PMID 36702538

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

Because we obtained highly significant results for BAFF, sTACI, and the sTACI-BAFF complexes with cohort 1, we started the evaluation of a second cohort, from whom both serum and CSF were available.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.